| products for asthma | |
|
Professional drug or supplement consultation available online by secure email. All products are scientifically standardized to ensure quality, purity, and potency of their supplements. Browse our school to learn more about different supplements. Find here A recent study products in Japan indicates that B12 treatment helps in the growth and division of certain for immune system cells.11 These cells function to prevent the immune system from over-reacting asthma and products to allergens such as animals, for mold, dust, and pollen. They are called suppressor cells or CD8+ lymphocytes. They “put the brakes on the immune system”. this medicationTM is a 21-day treatment of B12 lozenges sucked on twice daily. this medicationTM may help patients with asthma hay fever by providing the patient’s suppressor cells with the sustained and elevated blood B12 level they need to grow and divide. It appears that by helping the immune system to become what it is genetically capable of becoming, this medicationTM turns at least some allergic people into non-allergic or moderately-allergic people. Studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. When B12 is delivered via injection products and for or lozenge it passes throughout the bloodstream before arriving at the liver. It is during this first pass in its native asthma form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: "The World Health Organization (WHO) products recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in for which IgE-mediated allergy may be involved."1 In 1988, asthma and allergic rhinitis subjects asthma were treated with B12. Total IgE, specific IgE and pulmonary lung products functions were taken at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 In 1989 open label studies at two sites in Riverside for County, CA in 1989. Sixteen of the 17 subjects had lowered IgE levels from Day 0 to Day 30.3 Genentech and Novartis are developing an anti-IgE asthma monoclonal antibody for asthma and allergic rhinitis. In December 1999 they announced positive study results. This is evidence that reducing products IgE results in a reduction of symptoms associated with IgE-mediated allergic disease.13 For people who find they cannot for adequately asthma avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal products steroids, and cromolyn sodium - any of which can be used alone or in combination. Many effective for antihistamines and decongestants also are available without a prescription. Click here for allergy medication asthma online. |
|
| ©2003 www.nutritional-medicine-suppliers.com. All rights reserved | |